Mar 15, 2019 - Shares of Infinity (INFI) rise after the company inks deal with Roche to initiate a phase II MARIO-3 study on IPI-549. Per the deal, Roche will supply Tecentriq (atezolizumab) to Infinity.
Mar 15, 2019 - Merck (MRK) receives approval for Keytruda's combo therapy for first-line treatment of metastatic squamous non-small cell lung cancer population in Europe.
Mar 15, 2019 - Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others.
Mar 15, 2019 - J&J (JNJ) files sBLA seeking approval for Darzalex combination regimen in newly- diagnosed, transplant ineligible multiple myeloma patient population.
Mar 13, 2019 - Bristol-Myers Squibb Company (NYSE:BMY) Barclays 2019 Global Healthcare Conference Call March 13, 2019 12:30 ET Company Participants Charles Bancroft - CFO Conference Call Participants Geoff Meacham -
Mar 12, 2019 - Bristol-Myers Squibb Co (NYSE:BMY) Cowen Health Care Conference Call March 12, 2019, 11:20 AM ET Company Participants Christopher Boerner - EVP & Chief Commercial Officer Giovanni Caforio - Chairm
Mar 12, 2019 - Bristol-Myers Squibb Co. (NYSE:BMY) Cowen Health Care Conference Call March 12, 2019, 11:20 AM ET Company Participants Christopher Boerner - EVP & Chief Commercial Officer Giovanni Caforio - Chair
Mar 12, 2019 - Celgene (CELG) submits application for MS drug, ozanimod to the European Medicines Agency.
Mar 11, 2019 - Bayer (BAYRY) submits an MAA for darolutamide in EU for the treatment of patients with non-metastatic castration-resistant prostate cancer.
Mar 11, 2019 - Let's see if Bristol-Myers (BMY) stock is a good choice for value-oriented investors right now from multiple angles.